annual shareholder meeting presentation outline june, 20, 2016

23
Forward Looking Statements The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2015. Science & Technology Water – Air – Food – Plants – Animals – People Making them Clean Safe & Healthy Impacting the World

Upload: dennis-calvert

Post on 18-Jan-2017

2.046 views

Category:

Business


2 download

TRANSCRIPT

Page 1: Annual shareholder meeting presentation outline June, 20, 2016

Forward Looking StatementsThe statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2015.

Science & Technology

Water – Air – Food – Plants – Animals – People

Making them Clean Safe & Healthy

Impacting the World

Page 2: Annual shareholder meeting presentation outline June, 20, 2016

About biolargo

2

Industrial & consumer products

Water disinfection / dosing

Water disinfection & decontamination

Wound care & disinfection

Page 3: Annual shareholder meeting presentation outline June, 20, 2016

Recent HighlightsCupriDyne Clean Industrial odor control

products wins customers & poised for growth

Wound care division secures funding & expert support targets FDA application Q 1 2017

AOS named Innovation Leader for waste water industry – grants stack up – first commercial prototype due August 2016

Isan secures first EPA label June 20163

Page 4: Annual shareholder meeting presentation outline June, 20, 2016

Most recent news Technology Innovation Leader

in the water treatment market by global research company- Frost & Sullivan

“2015 New Product Innovation Award for The Water Treatment Industry – North America”

Copy of report available at www.biolargo.com

4

Page 5: Annual shareholder meeting presentation outline June, 20, 2016

AOS - Targeting high-value needs

5

Pick a lane to WIN!

Page 6: Annual shareholder meeting presentation outline June, 20, 2016

AOS Impact may Extend to Every Segment of the $360 billion Global Water Industry

6

Page 7: Annual shareholder meeting presentation outline June, 20, 2016

BIOLARGO’s AOS FILTER Converts a filter into a powerful reactor to manage and remove harmful contaminants

7

A SCALABLE WATER TECHNOLOGY

Page 8: Annual shareholder meeting presentation outline June, 20, 2016

The BioLargo Advanced Oxidation System (AOS) Filter

HOW IT WORKS

8

“Unprecedented Results”*Professor Lynn McMullen, University

of Alberta

Carbon Iodine Chemistry Electricity *Extremely HighOxidation Potential

Page 9: Annual shareholder meeting presentation outline June, 20, 2016

Unique Value propositionWhen compared to all known competing technologies, BioLargo’s AOS filter has been proven in hundreds of lab tests at the University of Alberta to be:

9

up to 100x more effective

1/20th the cost 10x faster

Page 10: Annual shareholder meeting presentation outline June, 20, 2016

Aos Filter: highest impact Disinfection: +7 log kill (99.99999%) Removes Soluble Organics Manages Bacterial BioFilm Extreme Power Efficiency Flow-Rate Efficiency (continuous) Practical application for recapture of

waste stream contaminants Low Cost (Cap X + Op X)

10

Page 11: Annual shareholder meeting presentation outline June, 20, 2016

Salmonella case study155,000 deaths per year94 million cases per yearUSDA Reports cost at $2.65B annuallyThe study compared our technology to the industry standard for combating Salmonella (Chlorine Dioxide)

11

STUDY RESULTS

Page 12: Annual shareholder meeting presentation outline June, 20, 2016

AOS - Development Cycle (targets)

Generation I - Point of Flow Modular System• Disinfection (Commercial Prototype August 2016) • Soluble Organics Destruction / Removal (Optimized: 2017)• Extraction / Recovery of Valuable Components of Waste

Stream (Optimized: 2017 – 2018)

Generation II - Fluidized Bed System • High Volume Capability• Extremely Low Reactor Cost• Gravity vs. Pump Driven System• Breakthrough Carbon Credit Delivery • Breakthrough Power Delivery System Drives AOS

Reactions12

Page 13: Annual shareholder meeting presentation outline June, 20, 2016

Low Cost & Low Power Generation I

Low Cap-X• Equivalent to Carbon System• < ½ the Cap Ex of an Ozone or UV System

Low Power (Op-X)• The incremental addition of energy to generate

the extremely high oxidation potential is deminimis to achieve high level disinfection

• The addition of energy to generate the extremely high oxidation potential to destroy soluble organics is estimated at less than 1/20th the cost of the nearest technical competitor

13

Page 14: Annual shareholder meeting presentation outline June, 20, 2016

Patented technology

Breaking Records at the University of Alberta

Grants Patents Discovery Commercialization

14

Page 15: Annual shareholder meeting presentation outline June, 20, 2016

Assets built to license:Advanced wound care

Financing Secured Proof of Efficacy AccomplishedPathway to Success is clear for $1B+ opportunity– 510k pathway – experts contracted &

underway Manufacturing, Formulation, Packaging, Labeling, Regulatory

Proven Leadership Team Liquids, Hydrogels & DressingsHigh Profit Margins

15

Page 16: Annual shareholder meeting presentation outline June, 20, 2016

Cupridyne cleanIndustrial Odor Control

16

Unprecedented performance

Large highly fragmented industry

Dissatisfied with old products

Odor control a top priority

Free trial & satisfaction guarantee

Sales network activatingKey accounts LOVE IT!

Page 17: Annual shareholder meeting presentation outline June, 20, 2016

Industrial and Consumer Products Assets

Over 30 Fully Developed Products - Demo Sells Products Instantly - Multiple Product of the Year Awards - Best-In-Class (Validated Bureau Veritas) US Military National Stocking

Numbers in Place (GSA-VA-DLA-DAPA) New Markets Opening Now

(Industrial Odor Control) Sales Targeted to Increase in 2016

17

Page 18: Annual shareholder meeting presentation outline June, 20, 2016

Isan - licensed & commercial

18

AOS Cylinder

EPA Approved June 2016 Licensing Agreement with Clarion Water

Page 19: Annual shareholder meeting presentation outline June, 20, 2016

Poultry Biosecurity SolutionsAqueous Iodine Sanitation Systems

Page 20: Annual shareholder meeting presentation outline June, 20, 2016

Contents

• Poultry Biosecurity Risks• iSAN® Systems• Clarion Company Snapshot• Lifecycle Support Services• Wrap Up

Page 21: Annual shareholder meeting presentation outline June, 20, 2016

iSAN® Systems

• Specifications• Capacity: up to 750 gallons per minute

at recommended poultry dosing levels.• Ability to capture all sanitation

byproducts through proprietary anion exchange capture resin system.

• Full data logging and audit capability.• 24x7 remote monitoring.• User-friendly, touch screen HMI.• Can be enclosed or unenclosed.

Page 22: Annual shareholder meeting presentation outline June, 20, 2016

Key benchmarks ahead AOS market-ready prototype contracted for delivery

August 2016 Successful Commercial Scale Pilots Expanded Grants / Collaborations Establish strategic partnerships New capital is required for product development, manufacturing and launch products Expand Existing Orders First AOS Commercial Sales Fortify the Management Team Extend Marketing and Sales Target Up-List to NASDAQ

22

Page 23: Annual shareholder meeting presentation outline June, 20, 2016

Company Contact:

Dennis Calvert President & CEOBioLargo, Inc.(949) [email protected] www.biolargo.com